117 related articles for article (PubMed ID: 3998205)
21. Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parameters.
Antal EJ; Lawson IR; Alderson LM; Chapron DJ; Kramer PA
J Clin Psychopharmacol; 1982 Jun; 2(3):193-8. PubMed ID: 7096608
[TBL] [Abstract][Full Text] [Related]
22. The contribution of pharmacokinetics to the best use of benzodiazepines and antidepressants.
Gram LF
Encephale; 1982; 8(2):291-8. PubMed ID: 6125380
[TBL] [Abstract][Full Text] [Related]
23. Rapid desipramine dose adjustment using 24-hour levels.
Nelson JC; Jatlow PI; Mazure C
J Clin Psychopharmacol; 1987 Apr; 7(2):72-7. PubMed ID: 3584524
[TBL] [Abstract][Full Text] [Related]
24. Amitriptyline and nortriptyline plasma levels monitoring. Perspective in clinical practice.
Corona GL; Zerbi F; Pinelli P; Fenoglio L; Frattini P; Cucchi ML; Santagostino G
Commun Psychopharmacol; 1980; 4(4):309-16. PubMed ID: 7273704
[No Abstract] [Full Text] [Related]
25. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents.
Wilens TE; Biederman J; Spencer T; Geist DE
J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):270-7. PubMed ID: 8444754
[TBL] [Abstract][Full Text] [Related]
26. Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity.
Bertschy G; Vandel S; Vandel B; Allers G; Bechtel P; Volmat R
Pharmacopsychiatry; 1989 Jul; 22(4):161-4. PubMed ID: 2762378
[TBL] [Abstract][Full Text] [Related]
27. The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.
Burch JE
Psychopharmacology (Berl); 1983; 80(3):254-8. PubMed ID: 6412270
[TBL] [Abstract][Full Text] [Related]
28. Prediction of steady-state nortriptyline plasma levels by the repeated one-point method.
Fant WK; Ritschel WA; Alwis SK; Roe S; Ehret J
Clin Pharmacokinet; 1984; 9(5):450-6. PubMed ID: 6499343
[TBL] [Abstract][Full Text] [Related]
29. Clinical pharmacology of antidepressant drugs: pharmacogenetics.
Sjöqvist F; Bertilsson L
Adv Biochem Psychopharmacol; 1984; 39():359-72. PubMed ID: 6380229
[TBL] [Abstract][Full Text] [Related]
30. Nortriptyline therapy in elderly patients: dosage prediction from plasma concentration at 24 hours after a single 50 mg dose.
Dawling S; Crome P; Heyer EJ; Lewis RR
Br J Psychiatry; 1981 Nov; 139():413-6. PubMed ID: 7332844
[TBL] [Abstract][Full Text] [Related]
31. [Relation of plasma amitriptyline and nortriptyline levels to the therapeutic response in endogenous depression].
Garaj V; Frank V; Drímalová M; Móric R; Pullmann R
Cesk Psychiatr; 1986 Oct; 82(5):307-12. PubMed ID: 3791462
[No Abstract] [Full Text] [Related]
32. Relationship of free nortriptyline levels to therapeutic response.
Perry PJ; Browne JL; Alexander B; Pfohl BM; Dunner FJ; Sherman AD; Tsuang MT
Acta Psychiatr Scand; 1985 Aug; 72(2):120-5. PubMed ID: 4050504
[TBL] [Abstract][Full Text] [Related]
33. Plasma concentrations of amitriptyline during single nightly and thrice daily administration. Cross-over study.
De Maio D; Drago F; Nielsen P; Ascalone V; Cisternino M
Arzneimittelforschung; 1980; 30(2):335-7. PubMed ID: 7378116
[TBL] [Abstract][Full Text] [Related]
34. Prospective study of scheduled withdrawal from nortriptyline in children and adolescents.
Geller B; Cooper TB; Carr LG; Warham JE; Rodriguez A
J Clin Psychopharmacol; 1987 Aug; 7(4):252-4. PubMed ID: 3624507
[TBL] [Abstract][Full Text] [Related]
35. Serial ECG measurements at controlled plasma levels of nortriptyline in depressed children.
Geller B; Farooki ZQ; Cooper TB; Chestnut EC; Abel AS
Am J Psychiatry; 1985 Sep; 142(9):1095-7. PubMed ID: 4025630
[TBL] [Abstract][Full Text] [Related]
36. A sensitive method for the determination of amitriptyline and nortriptyline in human plasma.
Cooper TB; Allen D; Simpson GM
Psychopharmacol Commun; 1976; 2(2):105-16. PubMed ID: 981709
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
[TBL] [Abstract][Full Text] [Related]
38. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation.
Reynolds CF; Buysse DJ; Brunner DP; Begley AE; Dew MA; Hoch CC; Hall M; Houck PR; Mazumdar S; Perel JM; Kupfer DJ
Biol Psychiatry; 1997 Oct; 42(7):560-7. PubMed ID: 9376452
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic protocol for predicting plasma nortriptyline levels.
Browne JL; Perry PJ; Alexander B; Sherman AD; Tsuang MT; Dunner FJ; Pfohl BM
J Clin Psychopharmacol; 1983 Dec; 3(6):351-6. PubMed ID: 6643702
[No Abstract] [Full Text] [Related]
40. Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design.
Geller B; Cooper TB; McCombs HG; Graham D; Wells J
Psychopharmacol Bull; 1989; 25(1):101-8. PubMed ID: 2672066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
